Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach.

Autor: Roeker LE; Memorial Sloan Kettering Cancer Center, New York, New York., Feldman TA; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey., Soumerai JD; Center for Lymphoma, Massachusetts General Hospital, Boston, Massachusetts., Falco V; Memorial Sloan Kettering Cancer Center, New York, New York., Panton G; Memorial Sloan Kettering Cancer Center, New York, New York., Dorsey C; Memorial Sloan Kettering Cancer Center, New York, New York., Zelenetz AD; Memorial Sloan Kettering Cancer Center, New York, New York., Falchi L; Memorial Sloan Kettering Cancer Center, New York, New York., Park JH; Memorial Sloan Kettering Cancer Center, New York, New York., Straus DJ; Memorial Sloan Kettering Cancer Center, New York, New York., Pena Velasquez C; Memorial Sloan Kettering Cancer Center, New York, New York., Lebowitz S; Memorial Sloan Kettering Cancer Center, New York, New York., Fox Y; Memorial Sloan Kettering Cancer Center, New York, New York., Battiato K; Memorial Sloan Kettering Cancer Center, New York, New York., Laudati C; Memorial Sloan Kettering Cancer Center, New York, New York., Thompson MC; Memorial Sloan Kettering Cancer Center, New York, New York., McCarthy E; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey., Kdiry S; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey., Martignetti R; Center for Lymphoma, Massachusetts General Hospital, Boston, Massachusetts., Turpuseema T; TG Therapeutics, Inc., New York, New York., Purdom M; TG Therapeutics, Inc., New York, New York., Paskalis D; TG Therapeutics, Inc., New York, New York., Miskin HP; TG Therapeutics, Inc., New York, New York., Sportelli P; TG Therapeutics, Inc., New York, New York., Leslie LA; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey., Mato AR; Memorial Sloan Kettering Cancer Center, New York, New York.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Sep 15; Vol. 28 (18), pp. 3958-3964.